The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

Reminders of the killing of UnitedHealthcare CEO Brian Thompson were everywhere at this year's J.P. Morgan conference.

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...

Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.

San Francisco law enforcement and city leaders are gearing up for a big month ahead and are warning people to be on alert for ...

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

As I ran from interview to interview across San Francisco, I was consistently warmed by the stories I was told by biotech and ...